Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.
News Medical on MSN
Why Some Retinitis Pigmentosa Cases Went Undiagnosed for Decades
Researchers led by the Institute of Molecular and Clinical Ophthalmology Basel uncovered disease-causing variants in ...
News-Medical.Net on MSN
Study identifies PUF60 as a critical vulnerability in triple negative breast cancer
Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...
Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...
Molecular mechanism uncovered in mice by UC Santa Cruz researchers reveals how a father’s diet, stress, and other ...
AZoLifeSciences on MSN
Dual genetic mutations drive RNA mis-splicing and leukemia progression
Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
IOB researchers, in collaboration with a team from Radboud University Medical Center and partners from more than 100 institutions worldwide, identify new genetic cause of inherited blindness. The ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...
Access the Akari CEO Corner hereTAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback